N

NMS Group

91 employees

NMS Group is a provider of research and development services include oncology drug discovery, preclinical research, clinical development.

Basic info

Industry

research services

Sectors

Discovery by Nerviano Medical Sciences
Clinical development starting from First-Time-In-Man by Clioss
Preclinical research by Accelera
Consumer Research
From formulation to production of the active principle by Nerpharma
Turn-key oncological treatment from discovery to production

Date founded

2012

Funding rounds raised

Total raised

$221M

from 1 investors over 1 rounds

N

NMS Group raised $221M on January 21, 2022

Investors: PAG

FAQ